Treatment of advanced malignant lymphomas with bleomycin.
D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D001761:Bleomycin / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D004338:Drug Combinations; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D007770:L-Lactate Dehydrogenase / Q000097:blood; D008168:Lung / Q000000981:diagnostic imaging; D008223:Lymphoma / Q000188:drug therapy*; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D011344:Procarbazine / Q000627:therapeutic use; D011859:Radiography; D012075:Remission, Spontaneous; D012129:Respiratory Function Tests; D014750:Vincristine / Q000627:therapeutic use
D000903:Antibiotics, Antineoplastic; D004338:Drug Combinations; D009588:Nitrogen Mustard Compounds; D001761:Bleomycin; D011344:Procarbazine; D014750:Vincristine; D003520:Cyclophosphamide; D007770:L-Lactate Dehydrogenase; D011241:Prednisone